New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - cefepime dihydrochloride monohydrate 2.30368 g equivalent to 2 g cefepime free base; cefepime dihydrochloride monohydrate 2.378 g equivalent to 2 g cefepime free base - powder for injection - 2 g - active: cefepime dihydrochloride monohydrate 2.30368 g equivalent to 2 g cefepime free base excipient: arginine active: cefepime dihydrochloride monohydrate 2.378 g equivalent to 2 g cefepime free base excipient: arginine - cefepime mylan is indicated in adults for the treatment of the infections listed below when caused by susceptible bacteria. · lower respiratory tract infections, including pneumonia and bronchitis. · urinary tract infections, both complicated, including pyelonephritis, and uncomplicated infections. · skin and skin structure infections. · septicaemia. · intra-abdominal infections, including peritonitis and biliary tract infections. · empiric treatment of febrile neutropenia.

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - cefepime dihydrochloride monohydrate 575.9mg equivalent to 500 mg cefepime free base;   - powder for injection - 500 mg - active: cefepime dihydrochloride monohydrate 575.9mg equivalent to 500 mg cefepime free base   excipient: arginine - cefepime mylan is indicated in adults for the treatment of the infections listed below when caused by susceptible bacteria. · lower respiratory tract infections, including pneumonia and bronchitis. · urinary tract infections, both complicated, including pyelonephritis, and uncomplicated infections. · skin and skin structure infections. · septicaemia. · intra-abdominal infections, including peritonitis and biliary tract infections. · empiric treatment of febrile neutropenia.

New Zealand - English - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - cefepime dihydrochloride monohydrate 1 g - powder for injection - 1 g - active: cefepime dihydrochloride monohydrate 1 g excipient: arginine - indicated for the treatment of lower respiratory tract infections, including pneumonia and bronchitis, when caused by susceptible bacteria.

New Zealand - English - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - cefepime dihydrochloride monohydrate 2 g - powder for injection - 2 g - active: cefepime dihydrochloride monohydrate 2 g excipient: arginine - indicated for the treatment of lower respiratory tract infections, including pneumonia and bronchitis, when caused by susceptible bacteria.

United States - English - NLM (National Library of Medicine)

apotex corporation - cefepime hydrochloride (unii: i8x1o0607p) (cefepime - unii:807pw4vqe3) - cefepime 1 g - cefepime for injection is indicated in the treatment of pneumonia (moderate to severe) caused by susceptible strains of streptococcus pneumoniae , including cases associated with concurrent bacteremia, pseudomonas aeruginosa , klebsiella pneumoniae , or enterobacter species. cefepime as monotherapy is indicated for empiric treatment of febrile neutropenic patients. in patients at high risk for severe infection (including patients with a history of recent bone marrow transplantation, with hypotension at presentation, with an underlying hematologic malignancy, or with severe or prolonged neutropenia), antimicrobial monotherapy may not be appropriate. insufficient data exist to support the efficacy of cefepime monotherapy in such patients [see clinical studies (14.1)]. cefepime is indicated in the treatment of uncomplicated and complicated urinary tract infections (including pyelonephritis) caused by susceptible isolates of escherichia coli or klebsiella pneumoniae , when the infection is severe, or caused by

Australia - English - Department of Health (Therapeutic Goods Administration)

cefepime hydrochloride monohydrate -

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

aft pharmaceuticals (se asia) sdn bhd - cefepime hydrochloride monohydrate -

Singapore - English - HSA (Health Sciences Authority)

fresenius kabi (singapore) pte ltd - cefepime dihydrochloride monohydrate 1189.2mg eqv cefepime - injection, powder, for solution - cefepime dihydrochloride monohydrate 1189.2mg eqv cefepime 1000 mg/vial

Singapore - English - HSA (Health Sciences Authority)

fresenius kabi (singapore) pte ltd - cefepime dihydrochloride monohydrate 2378.5mg eqv cefepime - injection, powder, for solution - cefepime dihydrochloride monohydrate 2378.5mg eqv cefepime 2000 mg/vial

United States - English - NLM (National Library of Medicine)

hospira, inc. - cefepime hydrochloride (unii: i8x1o0607p) (cefepime - unii:807pw4vqe3) - cefepime 1 g